Background Recently, evidence from a large randomised controlled trial (RCT) negated
efficacy of Lactobacillus rhamnosus GG for treating acute gastroenteritis in children. Aim To …

The effectiveness of Lactobacillus reuteri DSM 17938 (L. reuteri) for the management of
acute gastroenteritis (AGE) has been recently questioned. We performed a systematic …

Background The efficacy of each probiotic should be evaluated separately. Previously, we
have shown that L actobacillus GG (LGG) is effective in treating acute gastroenteritis (AGE) …

BACKGROUND Diarrhea is a major infectious cause of childhood morbidity and mortality
worldwide. In clinical trials, Lactobacillus rhamnosus GG ATCC 53013 (LGG) has been used …

Lactobacillus reuteri ATCC 55730 has been shown to provide a moderate clinical effect in
the treatment of acute gastroenteritis (AGE) in children. However, as the L. reuteri ATCC …

Aim To review evidence for the effectiveness of Lactobacillus GG (LGG) in treating acute
infectious diarrhoea in children. Methods The following electronic databases were searched …

Background Acute gastroenteritis develops in millions of children in the United States every
year, and treatment with probiotics is common. However, data to support the use of …

Aim Guidelines consider certain probiotics useful in the management of acute
gastroenteritis. This study evaluated the use of Lactobacillus (L) reuteri DSM 17938 …

Objective. Childhood diarrhea accounts for substantial morbidity and mortality worldwide.
Multiple studies in children have shown that Lactobacillus, administered orally, may have …

Aliment Pharmacol Ther 2011; 34: 1079–1087 Summary Background In children, healthcare‐
associated diarrhoea, in particular, due to rotavirus, may prolong the hospital stay and …